Loading...

Frélii

OTCPK:FRLI
Snowflake Description

Adequate balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
FRLI
OTCPK
$88M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Frélii, Inc. focuses on launching a Web-based subscription service providing personalized nutrition and wellness plans through its Website, frelii.com. The last earnings update was 10 days ago. More info.


Add to Portfolio Compare Print
FRLI Share Price and Events
7 Day Returns
5.6%
OTCPK:FRLI
3.6%
US Healthcare Services
0.9%
US Market
1 Year Returns
-
OTCPK:FRLI
29.4%
US Healthcare Services
9.6%
US Market
FRLI Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Frélii (FRLI) 5.6% 4.2% 5.6% - 1025% 1025%
US Healthcare Services 3.6% 6% 11.8% 29.4% 59.2% 58.5%
US Market 0.9% 4.6% 10.9% 9.6% 39% 47.2%
1 Year Return vs Industry and Market
  • No trading data on FRLI.
  • No trading data on FRLI.
Price Volatility
FRLI
Industry
5yr Volatility vs Market
Related Companies

FRLI Value

 Is Frélii undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Frélii . This is due to cash flow or dividend data being unavailable. The share price is $2.25.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Frélii 's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Frélii 's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:FRLI PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $-0.16
OTCPK:FRLI Share Price ** OTCPK (2019-04-25) in USD $2.25
United States of America Healthcare Services Industry PE Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 81.84x
United States of America Market PE Ratio Median Figure of 3,081 Publicly-Listed Companies 18.28x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Frélii .

OTCPK:FRLI PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OTCPK:FRLI Share Price ÷ EPS (both in USD)

= 2.25 ÷ -0.16

-14.37x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Frélii is loss making, we can't compare its value to the US Healthcare Services industry average.
  • Frélii is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Frélii 's expected growth come at a high price?
Raw Data
OTCPK:FRLI PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -14.37x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Healthcare Services Industry PEG Ratio Median Figure of 13 Publicly-Listed Healthcare Services Companies 2.75x
United States of America Market PEG Ratio Median Figure of 2,113 Publicly-Listed Companies 1.57x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Frélii , we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Frélii 's assets?
Raw Data
OTCPK:FRLI PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $0.01
OTCPK:FRLI Share Price * OTCPK (2019-04-25) in USD $2.25
United States of America Healthcare Services Industry PB Ratio Median Figure of 35 Publicly-Listed Healthcare Services Companies 4.33x
United States of America Market PB Ratio Median Figure of 5,185 Publicly-Listed Companies 1.92x
OTCPK:FRLI PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OTCPK:FRLI Share Price ÷ Book Value per Share (both in USD)

= 2.25 ÷ 0.01

383.3x

* Primary Listing of Frélii .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Frélii is overvalued based on assets compared to the US Healthcare Services industry average.
X
Value checks
We assess Frélii 's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. Frélii has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

FRLI Future Performance

 How is Frélii expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Frélii has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
22.8%
Expected Healthcare Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Frélii expected to grow at an attractive rate?
  • Unable to compare Frélii 's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Frélii 's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare Frélii 's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:FRLI Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 22.8%
United States of America Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 11.5%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.5%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:FRLI Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:FRLI Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 0 -1 -6
2018-09-30 0 -1 -5
2018-06-30 0 -1 -3
2018-03-31 0 0 -1
2017-12-31 0 1
2017-09-30 0 1
2017-06-30 0 0
2017-03-31 0 0
2016-12-31 0 0
2016-09-30 0 0
2016-06-30 0 0
2016-03-31 0 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Frélii is high growth as no earnings estimate data is available.
  • Unable to determine if Frélii is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:FRLI Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Frélii Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:FRLI Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 -0.16
2018-09-30 -0.20
2018-06-30 -0.17
2018-03-31 -0.09
2017-12-31 0.25
2017-09-30 0.27
2017-06-30 0.24
2017-03-31 0.22
2016-12-31 -0.14
2016-09-30 -0.14
2016-06-30 -0.14
2016-03-31 -0.14

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Frélii will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine Frélii 's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Frélii 's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Frélii 's filings and announcements here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Frélii 's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Frélii has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

FRLI Past Performance

  How has Frélii performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Frélii 's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Frélii does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Frélii 's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Frélii 's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
Frélii 's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Frélii Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:FRLI Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 0.04 -5.55 4.07
2018-09-30 0.02 -5.31 4.11
2018-06-30 0.00 -3.04 3.00
2018-03-31 0.00 -0.85 0.99
2017-12-31 0.60 0.13
2017-09-30 0.53 0.04
2017-06-30 0.46 0.14
2017-03-31 0.43 0.15
2016-12-31 -0.27 0.18
2016-09-30 -0.27 0.18
2016-06-30 -0.27 0.18
2016-03-31 -0.28 0.19
2015-12-31 -0.27 0.19
2015-09-30 -0.28 0.19
2015-06-30 -0.28 0.19
2015-03-31 -0.28 0.19
2014-12-31 -0.27 0.18
2014-09-30 -0.27 0.18
2014-06-30 -0.25 0.18
2014-03-31 -0.25 0.18
2013-12-31 -0.25 0.18
2013-09-30 -0.23 0.17
2013-06-30 -0.26 0.18
2013-03-31 -0.27 0.20
2012-12-31 -0.27 0.19
2012-09-30 -0.83 0.20
2012-06-30 -1.02 0.29

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Frélii has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Frélii has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Frélii improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Frélii 's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Frélii has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

FRLI Health

 How is Frélii 's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Frélii 's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Frélii is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Frélii has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Frélii 's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Frélii has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Frélii Company Filings, last reported 3 months ago.

OTCPK:FRLI Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 0.23 0.00 0.06
2018-09-30 0.19 0.00 0.12
2018-06-30 0.04 0.09 0.05
2018-03-31 0.51 0.08 0.28
2017-12-31 0.31 0.04
2017-09-30 -1.27 1.30
2017-06-30 -1.22 1.23
2017-03-31 -1.18 0.87
2016-12-31 -1.80 0.95
2016-09-30 -1.74 0.95
2016-06-30 -1.67 0.95
2016-03-31 -1.61 0.95
2015-12-31 -1.53 0.95
2015-09-30 -1.47 0.95
2015-06-30 -1.40 0.95
2015-03-31 -1.33 0.95
2014-12-31 -1.26 0.93
2014-09-30 -1.19 0.94
2014-06-30 -1.12 0.93
2014-03-31 -1.05 0.92
2013-12-31 -0.99 0.92
2013-09-30 -0.92 0.35
2013-06-30 -1.33 0.75
2013-03-31 -1.26 0.73
2012-12-31 -1.20 0.38
2012-09-30 -1.15 0.71
2012-06-30 -1.07 0.67
  • Frélii has no debt.
  • Frélii currently has no debt however we can't compare to 5 years ago as we have no data for that period.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Frélii has less than a year of cash runway based on current free cash flow.
  • Frélii has less than a year of cash runway if free cash flow continues to grow at historical rates of 132.5% each year.
X
Financial health checks
We assess Frélii 's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Frélii has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

FRLI Dividends

 What is Frélii 's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Frélii dividends.
If you bought $2,000 of Frélii shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Frélii 's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Frélii 's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:FRLI Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Global Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 15 Stocks 1.3%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2008 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Frélii has not reported any payouts.
  • Unable to verify if Frélii 's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Frélii 's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Frélii has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Frélii 's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Frélii afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Frélii has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

FRLI Management

 What is the CEO of Frélii 's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Ian Jenkins
COMPENSATION $0
AGE 34
TENURE AS CEO 2 years
CEO Bio

Mr. Ian Geran Jenkins has been the Chief Executive Officer and Chief Financial Officer of Frélii, Inc. (formerly known as Vican Resources, Inc.) since April 5, 2017 and serve as President. Mr. Jenkins has been the Managing Partner of Unprescribed, LLC since 2016. He served as Director of Marketing from 2012 to 2016 at Systemic Formulas Inc., and an Industry Consultant from 2011 to 2012 at Project Based in Salt Lake City, Utah. Mr. Jenkins was a Turnaround Consultant with Coleridge Group - Phoenix, Arizona, from 2010 to 2011 and Chief Executive Officer of CodeTec - Phoenix, Arizona, from 2009 to 2010. He has been a Director of Frélii, Inc. since April 5, 2017. Mr. Jenkins received a Bachelor of Science in Exercise Physiology in 2007 from Utah State University and an MBA, International Business / Entrepreneurship in 2011 from the Thunderbird School of Global Management - Glendale, AZ.

CEO Compensation
  • Insufficient data for Ian to compare compensation growth.
  • Ian's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Frélii management team in years:

1.2
Average Tenure
37.5
Average Age
  • The average tenure for the Frélii management team is less than 2 years, this suggests a new team.
Management Team

Ian Jenkins

TITLE
President
AGE
34
TENURE
2 yrs

Jayson Uffens

TITLE
CTO & Director
AGE
43
TENURE
0.9 yrs

Seth Jones

TITLE
Chief Marketing Officer
AGE
29
TENURE
1.3 yrs

Hans Jenkins

TITLE
Chief Medical Officer & Director
AGE
41
TENURE
1.1 yrs
Board of Directors Tenure

Average tenure and age of the Frélii board of directors in years:

0.3
Average Tenure
45.5
Average Age
  • The average tenure for the Frélii board of directors is less than 3 years, this suggests a new board.
Board of Directors

Jim Spallino

TITLE
Chairman of the Board
AGE
59

Ian Jenkins

TITLE
President
AGE
34
TENURE
2 yrs

Jayson Uffens

TITLE
CTO & Director
AGE
43

Hans Jenkins

TITLE
Chief Medical Officer & Director
AGE
41
TENURE
1.1 yrs

Tarek Mango

TITLE
Director
AGE
48
TENURE
1.3 yrs

Leslie Norris

TITLE
Director
AGE
59
TENURE
0.3 yrs

Anthony Torres

TITLE
Member of Scientific Advisory Committee
TENURE
0.2 yrs

Susan Morelli

TITLE
Member of Scientific Advisory Committee
TENURE
0.2 yrs

Shayne Morris

TITLE
Member of Scientific Advisory Committee
TENURE
0.2 yrs

Shannon Jenkins

TITLE
Member of Scientific Advisory Committee
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Frélii 's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Frélii has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

FRLI News

Simply Wall St News

FRLI Company Info

Description

Frélii, Inc. focuses on launching a Web-based subscription service providing personalized nutrition and wellness plans through its Website, frelii.com. It offers lab diagnostics kits, compounded pharmaceuticals, and nutritional and vitamin supplements. The company was formerly known as Vican Resources, Inc. and changed its name to Frélii, Inc. in March 2018. The company is based in Lehi, Utah.

Details
Name: Frélii, Inc.
FRLI
Exchange: OTCPK
Founded:
$88,419,240
39,297,440
Website: http://www.frelii.com
Address: Frélii, Inc.
2701 North Thanksgiving Way,
Suite 100,
Lehi,
Utah, 84043,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OTCPK FRLI Class A Common Stock Pink Sheets LLC US USD 03. Aug 2009
Number of employees
Current staff
Staff numbers
9
Frélii employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/26 02:34
End of day share price update: 2019/04/25 00:00
Last earnings filing: 2019/04/16
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.